Household and personal care company Godrej Consumer Products Ltd (GCPL) on Friday reported a 109.2% jump in consolidated net profit (after adjustment of exceptional items) at Rs.244.89 crore during the quarter ended 30 June, driven by strong operational metrics, despite slow sales growth.
Advertisement
The results are not comparable in view of acquisitions and changes in the company’s shareholding in some of the subsidiaries, said GCPL, which acquired US-based Strength of Nature LLC, in April this year.
PVR’s consolidated net sales were up 17.19 per cent to Rs 559.96 crore during the quarter under review as against Rs 477.81 crore in the year-ago period. It was Rs 1,985.43 crore in the corresponding quarter.
However, standalone total income from operations of the company rose to Rs 705.33 crore during the quarter as against Rs 651.70 crore in the corresponding period of the previous fiscal.
“We delivered this performance despite the sluggish business environment across many geographies that we are present in”. Torrent Pharmaceuticals Q1FY17 results were impacted largely on account of fall in the U.S. business (51 per cent YoY), which stood at Rs 434 crore as against Rs 888 crore in Q1FY2016.
For “Others” segment, which includes bowling, gaming and restaurants, earning was up 12.60 per cent to Rs 20.37 crore as against Rs 18.09 crore in the first quarter last fiscal. So far 45788 shares were traded on the counter.
Advertisement
Alembic Pharmaceuticals shares were trading up by 2.5 per cent at Rs 628.05 on the National Stock Exchange.
